Back

Combined elevation of lipoprotein(a) and polygenic risk in index patients identifies family members at high risk of coronary artery disease

31 August 2026 (14:42 - 14:54)
Organised by: Logo
Congress Presentation Part of: Metabolic risk scores and atherosclerotic cardiovascular disease Epidemiology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Maxim Eduard Annink

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Association of Life's Essential 8 and psoriasis-atherosclerotic cardiovascular disease (PSO-ASCVD) comorbidity: a prospective cohort study
Doctor F. Tan (Beijing, CN)
Abstract
Presentation thumbnail
Association between lipoprotein(a) and ischemic brain lesions in patients with atrial fibrillation: insight from the Swiss-AF cohort
Doctor N. Johner (Bordeaux, FR)
Abstract
Presentation thumbnail
The metabolic score for insulin resistance (METS-IR) predicts MACE and is correlated to plasma levels of leptin and sRAGE: validation and mechanistic insights from a Swedish population-based cohort
Doctor F. Hammareus (Linkoping, SE)
Abstract
Presentation thumbnail
Proteomic signatures reveal why not all apolipoprotein B-containing lipoproteins are equal in atherosclerosis
Doctor J. Morze (Gothenburg, SE)
Abstract

Access the full session

Session thumbnail
Metabolic risk scores and atherosclerotic cardiovascular disease

The Event

Event poster

ESC Congress 2026

31 August 2026 14:42 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions
28 August 2020
thumbnail
Webinar
Polygenic risk scores: what is their value for risk prediction and potential for clinical utility?
22 March 2022
thumbnail
Congress Presentation
LipoaScreen – cascade screening for lipoprotein(a)
1 September 2025
thumbnail
Congress Presentation
Major cardiovascular events in first-degree relatives to individuals with elevated plasma lipoprotein(a) a registry-based cohort study
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources